Literature DB >> 10807460

Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study.

J Schofer1, M Schlüter, T Rau, F Hammer, N Haag, D G Mathey.   

Abstract

OBJECTIVES: This retrospective study was designed to determine the six-month angiographic outcome after stenting of native coronary arteries in insulin-treated (ITDM) and non-ITDM patients with diabetes mellitus (DM) and compare the results with those in non-DM patients.
BACKGROUND: The influence of the treatment modality for DM on restenosis in patients undergoing coronary artery stenting has not been elucidated sufficiently.
METHODS: A total of 1,439 (70%) of 2,061 patients underwent repeated angiography within six months of coronary stenting. The ITDM and non-ITDM (oral hypoglycemic drugs or diet) were documented in 48 (3.3%) and 177 patients (12.3%), respectively, leaving 1,214 non-DM patients.
RESULTS: Baseline reference vessel diameter tended to be smaller in ITDM patients (mean, 2.73 mm) than in non-DM and non-ITDM patients (2.88 mm and 2.85 mm, respectively). However, percent diameter stenosis was not different. The median number of stents deployed was 1; median stent length was 15 mm. Statistically significant differences were present after stenting for the means of minimal lumen diameter (MLD) and acute gain between ITDM patients (MLD: 2.67 mm, acute gain: 1.98 mm) and non-DM patients (MLD: 2.81 mm, acute gain: 2.16 mm). At follow-up, percent diameter stenosis, late lumen loss and loss index were significantly higher in both non-ITDM lesions (42%, 1.14 mm and 0.56, respectively) and ITDM lesions (48%, 1.26 mm and 0.65, respectively) than in non-DM lesions (35%, 0.96 mm and 0.45, respectively). The corresponding differences between non-ITDM and ITDM lesions did not reach statistical significance. Restenosis rates in non-DM, non-ITDM and ITDM lesions were 23.8%, 32.8% (p = 0.013 vs. non-DM) and 39.6% (p = 0.02 vs. non-DM, p = 0.477 vs. non-ITDM), respectively.
CONCLUSIONS: This study showed that compared with stenting in non-DM patients, stenting of native coronary arteries in DM patients is associated with significantly increased lumen renarrowing, regardless of the treatment modality for DM.

Entities:  

Mesh:

Year:  2000        PMID: 10807460     DOI: 10.1016/s0735-1097(00)00574-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Percutaneous coronary intervention in diabetics.

Authors:  Juhana Karha; Deepak L Bhatt
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat.

Authors:  Xiaoyong Tong; Xiuyun Hou; David Jourd'heuil; Robert M Weisbrod; Richard A Cohen
Journal:  Circ Res       Date:  2010-08-19       Impact factor: 17.367

3.  Unraveling the links between diabetes, obesity, and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Circ Res       Date:  2005-06-10       Impact factor: 17.367

4.  Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.

Authors:  Margo Klomp; Peter Damman; Marcel A M Beijk; Sigmund Silber; Manfred Grisold; Expedito E Ribeiro; Harry Suryapranata; Jaroslaw Wòjcik; Kui Hian Sim; Jan G P Tijssen; Robbert J de Winter
Journal:  Heart Vessels       Date:  2011-07-02       Impact factor: 2.037

5.  Outcome of diabetic and non-diabetic patients undergoing successful percutaneous coronary intervention of chronic total occlusion.

Authors:  Bahram Sohrabi; Samad Ghaffari; Afshin Habibzadeh; Parastoo Chaichi
Journal:  J Cardiovasc Thorac Res       Date:  2011-05-28

Review 6.  Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

Review 7.  How to revascularize patients with diabetes mellitus: bypass or stents and drugs?

Authors:  Albrecht Elsässer; Helge Möllmann; Holger M Nef; Christian W Hamm
Journal:  Clin Res Cardiol       Date:  2006-02-27       Impact factor: 5.460

8.  Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.

Authors:  S J Hong; M H Kim; T H Ahn; Y K Ahn; J H Bae; W J Shim; Y M Ro; D-S Lim
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

9.  Angiographic characteristics of the coronary artery in patients with type 2 diabetes.

Authors:  Tong-Guo Wu; Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2002

10.  Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.

Authors:  Seyed Ebrahim Kassaian; Hamidreza Goodarzynejad; Mohammad Ali Boroumand; Mojtaba Salarifar; Farzad Masoudkabir; Mohammad Reza Mohajeri-Tehrani; Hamidreza Pourhoseini; Saeed Sadeghian; Narges Ramezanpour; Mohammad Alidoosti; Elham Hakki; Soheil Saadat; Ebrahim Nematipour
Journal:  Cardiovasc Diabetol       Date:  2012-07-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.